L. Bertolini et al., Low cell dosage of lymphoblastoid human cell lines EBV+ is associated to chronic hepatitis in a minority of inoculated nu/nu mice, J MED VIROL, 66(1), 2002, pp. 70-81
It has been suggested that an atypical course of primary infection by EBV a
nd the reactivation of EBV infection in transplanted patients may induce he
patitis. We explored the possibility to dissect the infectious activity fro
m the ability to promote B lymphocyte proliferation in vivo by injecting in
nu/nu mice a low number (2 x 10(6) - 0.05 x 10(6)) of cells from CE a norm
al human bone marrow-derived B cell line. This line carries an endogenous E
BV in episomal and linear forms. Twenty nu/nu mice were inoculated subcutan
eously with the B cell line CE and a matched group with the cell line RAG o
btained by EBV in vitro infection of normal human peripheral blood. The mic
e injected with the CE line did not develop a lymphoproliferative disease,
but 5 of them displayed typical histopathological lesions of chronic hepati
tis without involvement of other organs. Similar results were obtained in 2
out of 20 animals in the RAG group. A close association between liver lesi
ons and a previous EBV infection, by putative circulating B lymphoblastoid
cells releasing their EBV, was established by PCR and by in situ hybridizat
ion with BamHI "W" DNA probe. This latter probe detected the presence of ab
out 15% of positive cells only in affected livers. In addition, the rare de
tection in some hepatocytes of "A" type Cowdry bodies would suggest the occ
urrence of continuous EBV replication although at a very low level, These d
ata show that we succeeded in dissecting the infectious from the proliferat
ive activity of the endogenous EBV carrier CE cell line. This provides in a
ddition a promising model for chronic EBV-associated hepatitis. (C) 2002 Wi
ley-Liss, Inc.